Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Horse chestnut (Aesculus hippocastanum) is scientifically validated to some extent for use in supporting chronic venous insufficiency (CVI), a condition closely related to phlebitis, which involves inflammation of veins. The active compound in horse chestnut, aescin (or escin), has been shown in clinical studies and meta-analyses to reduce leg swelling, pain, and other symptoms associated with venous disorders. Several randomized controlled trials have demonstrated that horse chestnut seed extract can be as effective as compression stockings in reducing leg edema. Its anti-inflammatory and vascular-protective actions are attributed to aescin, which helps strengthen vein walls, reduce fluid leakage, and decrease inflammation. However, while the evidence for CVI is substantial, direct high-quality studies specifically targeting phlebitis (especially acute or superficial forms) are limited. Most clinical research focuses on chronic venous disorders rather than acute vein inflammation. Despite this, the overlap in pathology means that practitioners sometimes extrapolate the benefits seen in CVI to mild forms of phlebitis. The European Medicines Agency and other regulatory bodies recognize the use of horse chestnut for venous discomfort and swelling, lending further support for its use in vascular health. Nevertheless, it is not a substitute for medical treatment of more severe or thrombophlebitic conditions. Always consult a healthcare professional before starting supplementation.

More about horse chestnut
More about Phlebitis

Other ingredients used for Phlebitis

Other health conditions supported by horse chestnut

Products containing horse chestnut

Designs For Health Vessel Forte™